You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 21, 2024

Litigation Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)

Docket ⤷  Sign Up Date Filed 2019-09-15
Court United States Bankruptcy Court, S.D. New York Date Terminated
Cause Assigned To Sean H. Lane
Jury Demand Referred To
Parties BAYARD, P.A.; KROLL RESTRUCTURING ADMINISTRATION LLC
Patents 10,407,434; 6,488,963; 7,658,945; 8,313,778; 8,337,888; 8,722,684; 9,060,976; 9,073,933; 9,522,919
Attorneys Jeffrey R. Gleit; Nathan Yeary
Firms Office of the United States Trustee; Skadden, Arps, Slate, Meagher & Flom LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in Purdue Pharma L.P.
The biologic drug covered by the patents cited in this case is ⤷  Sign Up .

Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-07-20 1463 Response to Motion ,412, as U.S. Patent Nos. 8,337,888 (the “’888 patent”); 9,060,976 (the “’976 patent”); and 9,034,376…certain of the Debtors’ patents, including U.S. Patent No. 9,693,961 (“the ’961 Patent”). Shortly after the… Patent 9,693,961 B2 A. Related Proceedings Patent Owner asserted the ’961 patent against…Response, Patent Owner contends that, “transitional” continuation patents such as the ’961 patent are not…before the Patent Trial and Appeal Board (the “PTAB”), seeking a determination that the ’961 patent was invalid External link to document
2020-08-19 1592 Objection to Motion other patents in suit – U.S. Patent Nos. 9,073,933 (“’933 Patent”) and 9,522,919 (“’919 Patent”). These…of one of the Debtors’ patents, U.S. Patent No. 9,693,961 B2 (the “’961 Patent”). Collegium’s Response…’961 Patent — the subject of the PTAB Action — is just one of the patents in suit in the Patent Litigation…Action”) before the United States Patent and Trademark Office’s Patent Trial and Appeal Board (the “PTAB…These patents are not related to the ’961 Patent — they have different specifications, different records External link to document
2021-01-11 2247 Exhibit 15 U.S.P.N.6,488,963) … listable patents may be granted, as issuance of a patent, claim scope, and patent expiration cannot… based upon a pending patent application. • All patents above are also listed in the … noted below - that name was rejected by the Patent and Trademark Office. In order to maintain brand…application for T ARGIN was rejected by the United States Patent and Trademark Office based on similarity External link to document
2019-10-29 357 Schedules ATTN: GENERAL COUNSEL U.S. PAT. NO. 7,658,945 DATED MARCH …relating to patent litigation Undetermined Nature of claim: Patent Litigation…relating to patent litigation Undetermined Nature of claim: Patent Litigation…relating to patent litigation Undetermined Nature of claim: Patent Litigation …relating to patent litigation Undetermined Nature of claim: Patent Litigation External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.